MicroRNAs impair MET-mediated invasive growth

Area of Science:

• Molecular Biology
• Oncology
• Gene Regulation

Background:

• MicroRNAs (miRNAs) are small noncoding RNAs regulating gene expression post-transcriptionally.
• miRNAs are implicated in various biological processes, including cancer, acting as oncogenes or tumor suppressors.
• The MET oncogene, encoding a receptor tyrosine kinase, drives invasive growth and is frequently overexpressed in human tumors.

Purpose of the Study:

• To identify miRNAs that negatively regulate the MET oncogene.
• To investigate the functional consequences of modulating these miRNAs on MET signaling and cancer cell behavior.
• To explore the potential of these miRNAs as oncosuppressors targeting MET.

Main Methods:

• Identification of miRNAs targeting MET through computational prediction and experimental validation.
• Use of antagomiRs to inhibit endogenous miRNAs and assess MET protein expression.
• Exogenous expression of miRNAs in cancer cells to evaluate MET-induced signal transduction and invasive growth.
• Assessment of miRNA effects on MET-induced migratory ability in melanoma cells.

Main Results:

• Three specific miRNAs (miR-34b, miR-34c, and miR-199a*) were identified as negative regulators of MET expression.
• Inhibition of these miRNAs led to increased MET protein levels.
• Exogenous expression of these miRNAs suppressed MET-induced signaling, invasive growth, and migration in cancer and melanoma cells.
• These miRNAs demonstrated oncosuppressive activity by targeting the oncogenic MET pathway.

Conclusions:

• miR-34b, miR-34c, and miR-199a* function as tumor suppressors by negatively regulating MET.
• These miRNAs effectively block MET-induced invasive growth and cell motility.
• Targeting MET with these oncosuppressive miRNAs presents a potential therapeutic avenue for MET-deregulated cancers.